A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Stopped early · Phase 2
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The purpose of this study was to provide the opportunity to the participants who progressed on treatment arm previously in the study UTX-TGR-304 (NCT02612311) to receive ublituximab (TG-1101) treatment in combination with umbralisib (TGR-1202).
Key facts
- Study ID
- NCT02656303
- Run by
- TG Therapeutics, Inc.
- People needed
- 116
- Starts
- 2016-01-07
- Expected to finish
- 2022-07-11
- Last updated by the study team
- 2023-06-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Prior treatment in clinical trial UTX-TGR-304
- Eastern Cooperative Oncology Group (ECOG) score of 0 to 2
You may not qualify if…
- Participants refractory to ublituximab + TGR-1202
- Transformation of chronic lymphocytic leukemia (CLL) to aggressive Non-Hodgkin's Lymphoma (NHL) (Richter's transformation)
Where it is running
- TG Therapeutics Investigational Trial Site — Chandler, Arizona, United States
- TG Therapeutics Investigational Trial Site — Fayetteville, Arkansas, United States
- TG Therapeutics Investigational Trial Site — Duarte, California, United States
- TG Therapeutics Investigational Trial Site — Pleasanton, California, United States
- TG Therapeutics Investigational Trial Site — San Diego, California, United States
- TG Therapeutics Investigational Trial Site — Whittier, California, United States
- TG Therapeutics Investigational Trial Site — Aurora, Colorado, United States
- TG Therapeutics Investigational Trial Site — Denver, Colorado, United States
- TG Therapeutics Investigational Trial Site — Bridgeport, Connecticut, United States
- TG Therapeutics Investigational Trial Site — New Haven, Connecticut, United States
- TG Therapeutics Investigational Trial Site — Stamford, Connecticut, United States
- TG Therapeutics Investigational Trial Site — Newark, Delaware, United States
- TG Therapeutics Investigational Trial Site — Boca Raton, Florida, United States
- TG Therapeutics Investigational Trial Site — Fort Myers, Florida, United States
- TG Therapeutics Investigational Trial Site — Jacksonville, Florida, United States
- TG Therapeutics Investigational Trial Site — Jacksonville, Florida, United States
- TG Therapeutics Investigational Trial Site — St. Petersburg, Florida, United States
- TG Therapeutics Investigational Trial Site — Tallahassee, Florida, United States
- TG Therapeutics Investigational Trial Site — West Palm Beach, Florida, United States
- TG Therapeutics Investigational Trial Site — Albany, Georgia, United States
- TG Therapeutics Investigational Trial Site — Chicago, Illinois, United States
- TG Therapeutics Investigational Trial Site — Peoria, Illinois, United States
- TG Therapeutics Investigational Trial Site — Swansea, Illinois, United States
- TG Therapeutics Investigational Trial Site — Urbana, Illinois, United States
- TG Therapeutics Investigational Trial Site — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.